NIH-funded research R21 grant

Creating standards for accurate COVID-19 testing

Official title: Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards

Funded at Beth Israel Deaconess Medical Center · NIH-10993686 · Data updated 2026-11-12

This study is working on creating better tools for COVID-19 testing to help doctors know how much virus is in a person's body, which can improve diagnosis and treatment, especially for those with weakened immune systems.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBeth Israel Deaconess Medical Center
NIH-funded
Lab location1 site (Boston, United States)
Project startDecember 1, 2023
Project endOctober 31, 2025
Funding year2025
Award (this year)$251,570
NIH project number5R21AI176120-02
Project IDNIH-10993686 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals undergoing COVID-19 testing, especially those with varying viral loads or immunocompromised conditions.

Less likely to help

Patients who are not being tested for COVID-19 or those who have already recovered from the virus may not benefit from this research.

What this research studies

This research focuses on developing calibration standards for SARS-CoV-2 RT-qPCR assays, which are crucial for diagnosing COVID-19. By establishing a reliable method to convert cycle threshold values into accurate viral load measurements, the project aims to improve the accuracy of COVID-19 testing. This will help determine if individuals are infectious, assess treatment effectiveness in immunocompromised patients, and differentiate between current infections and residual viral RNA. The goal is to make these standards affordable and accessible for diagnostic and research laboratories.

Why it matters

Potential benefit: If successful, this research could lead to more accurate COVID-19 testing, improving patient management and treatment outcomes.

How similar studies have gone: Other research has successfully developed calibration standards for various diagnostic assays, indicating a promising potential for this approach in COVID-19 testing.

Where this research is happening

  • Beth Israel Deaconess Medical Center
    Boston, United States
    Active

Researchers

  • Principal investigator: Kirby, James E — Beth Israel Deaconess Medical Center
  • Study coordinator: Kirby, James E

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.